Skip to main content

Advertisement

SpringerLink
Log in

The association between urinary phytoestrogen excretion and components of the metabolic syndrome in NHANES

  • Original Contribution
  • Published:
European Journal of Nutrition Aims and scope Submit manuscript

Abstract

Background

Metabolic syndrome is a major risk factor for cardiovascular diseases, which are still the major cause of death in developed countries.

Methods

We cross-sectionally studied the association between urinary phytoestrogen excretion and metabolic cardiovascular risk factors. Hence, we used data from the National Health and Nutrition Examination Survey from 1999 to 2004 with 1,748 participants, who had urine levels of isoflavones and lignans measured. Geometric means of waist circumference, blood pressure, fasting glucose, HDL cholesterol, and triglyceride levels were computed by quartiles of isoflavone or lignan urinary excretion. Outcome was assessed as the presence of metabolic syndrome according to NCEP-ATP III criteria. The association between phytoestrogen concentration and the metabolic syndrome was calculated using logistic regression analyses.

Results

Plasma triglyceride and HDL cholesterol levels were lower in participants in the highest quartile of lignan excretion compared with the lowest (both P < 0.01). However, blood pressure, waist circumference, and plasma glucose levels did not differ significantly between extreme quartiles. The presence of metabolic syndrome was lower with increasing levels of urinary lignans (OR 0.48, 95 % CI 0.28; 0.80 top vs. bottom quartile), especially when separately computed for the excretion of enterolactone (OR 0.47, 95 % CI 0.28; 0.78). There was no significant association between isoflavone excretion and any component of the metabolic syndrome.

Conclusions

Our study shows that an increasing excretion of lignans, especially enterolactone, might be associated with a decreased presence of the metabolic syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Danaei G, Finucane MM, Lu Y et al (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378(9785):31–40. doi:10.1016/S0140-6736(11)60679-X

    Article  CAS  Google Scholar 

  2. World Health Organization WHO Diabetes. http://www.who.int/mediacentre/factsheets/fs312/en/index.html. Accessed 27 Nov 2012

  3. Starcke S, Vollmer G (2006) Is there an estrogenic component in the metabolic syndrome? Genes Nutr 1(3–4):177–188. doi:10.1007/BF02829967

    Article  CAS  Google Scholar 

  4. Saarinen NM, Bingham C, Lorenzetti S et al (2006) Tools to evaluate estrogenic potency of dietary phytoestrogens: a consensus paper from the EU Thematic Network “Phytohealth” (QLKI-2002-2453). Genes Nutr 1(3–4):143–158. doi:10.1007/BF02829964

    Article  CAS  Google Scholar 

  5. French MR, Thompson LU, Hawker GA (2007) Validation of a phytoestrogen food frequency questionnaire with urinary concentrations of isoflavones and lignan metabolites in premenopausal women. J Am Coll Nutr 26(1):76–82

    Article  CAS  Google Scholar 

  6. Frankenfeld CL, Patterson RE, Kalhorn TF et al (2002) Validation of a soy food frequency questionnaire with plasma concentrations of isoflavones in US adults. J Am Diet Assoc 102(10):1407–1413

    Article  Google Scholar 

  7. Cornwell T (2004) Dietary phytoestrogens and health. Phytochemistry 65(8):995–1016. doi:10.1016/j.phytochem.2004.03.005

    Article  CAS  Google Scholar 

  8. Bar-El DS, Reifen R (2010) Soy as an endocrine disruptor: cause for caution? J Pediatr Endocrinol Metab 23(9):855–861

    CAS  Google Scholar 

  9. Cederroth CR, Nef S (2009) Soy, phytoestrogens and metabolism: a review. Mol Cell Endocrinol 304(1–2):30–42. doi:10.1016/j.mce.2009.02.027

    Article  CAS  Google Scholar 

  10. Chun OK, Chung SJ, Song WO (2009) Urinary isoflavones and their metabolites validate the dietary isoflavone intakes in US adults. J Am Diet Assoc 109(2):245–254. doi:10.1016/j.jada.2008.10.055

    Article  CAS  Google Scholar 

  11. Frankenfeld CL (2011) Dairy consumption is a significant correlate of urinary equol concentration in a representative sample of US adults. Am J Clin Nutr 93(5):1109–1116. doi:10.3945/ajcn.111.011825

    Article  CAS  Google Scholar 

  12. Buck K, Zaineddin AK, Vrieling A et al (2010) Meta-analyses of lignans and enterolignans in relation to breast cancer risk. Am J Clin Nutr 92(1):141–153. doi:10.3945/ajcn.2009.28573

    Article  CAS  Google Scholar 

  13. Hwang YW, Kim SY, Jee SH et al (2009) Soy food consumption and risk of prostate cancer: a meta-analysis of observational studies. Nutr Cancer 61(5):598–606. doi:10.1080/01635580902825639

    Article  CAS  Google Scholar 

  14. Guthrie JR, Ball M, Murkies A et al (2000) Dietary phytoestrogen intake in mid-life Australian-born women: relationship to health variables. Climacteric 3(4):254–261

    Article  CAS  Google Scholar 

  15. Jayagopal V, Albertazzi P, Kilpatrick ES et al (2002) Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 25(10):1709–1714

    Article  CAS  Google Scholar 

  16. Greany KA, Nettleton JA, Wangen KE et al (2004) Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal women. J Nutr 134(12):3277–3283

    CAS  Google Scholar 

  17. Cheng S, Shaw N, Tsai K et al (2004) The hypoglycemic effects of soy isoflavones on postmenopausal women. J Womens Health (Larchmt) 13(10):1080–1086. doi:10.1089/jwh.2004.13.1080

    Article  Google Scholar 

  18. Anderson JW, Hoie LH (2005) Weight loss and lipid changes with low-energy diets: comparator study of milk-based versus soy-based liquid meal replacement interventions. J Am Coll Nutr 24(3):210–216

    Article  CAS  Google Scholar 

  19. Li Z, Hong K, Saltsman P et al (2005) Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur J Clin Nutr 59(3):411–418. doi:10.1038/sj.ejcn.1602089

    Article  CAS  Google Scholar 

  20. Anderson JW, Fuller J, Patterson K et al (2007) Soy compared to casein meal replacement shakes with energy-restricted diets for obese women: randomized controlled trial. Metabolism 56(2):280–288. doi:10.1016/j.metabol.2006.10.013

    Article  CAS  Google Scholar 

  21. FDA (1999) CFR—Code of Federal Regulations title 21. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=101.82. Accessed 01 Oct 2012

  22. Canada Go, Canada H, Health Products and Food Branch, Natural Health Products Directorate (2009) Technical report to summarize the scientific rationale for the natural health products directorate’s new guidance on the regulation of soy isoflavone products—health Canada. http://www.hc-sc.gc.ca/dhp-mps/prodnatur/legislation/docs/rapport_tech_report_soya-eng.php#b. Accessed 01 Oct 2012

  23. Bhupathy P, Haines CD, Leinwand LA (2010) Influence of sex hormones and phytoestrogens on heart disease in men and women. Womens Health (Lond Engl) 6(1):77–95. doi:10.2217/whe.09.80

  24. Peñalvo JL, López-Romero P (2012) Urinary enterolignan concentrations are positively associated with serum HDL cholesterol and negatively associated with serum triglycerides in U.S. adults. J Nutr 142(4):751–756. doi:10.3945/jn.111.150516

    Article  Google Scholar 

  25. NHANES CNCfHS (2012, March 30) NHANES–continuous NHANES web tutorial—survey design factors. http://www.cdc.gov/nchs/tutorials/NHANES/SurveyDesign/intro.htm. Accessed 01 Oct 2012

  26. NHANES CNCfHS (2012, Aug 30) NHANES—NHANES participants homepage. http://www.cdc.gov/nchs/nhanes/participant.htm. Accessed 01 Oct 2012

  27. NHANES CNCfHS (2012, Jan) NHANES 1999–2000: PHPYPA urinary phthalates data documentation, codebook, and frequencies. http://www.cdc.gov/nchs/nhanes/nhanes1999-2000/PHPYPA.htm. Accessed 01 Oct 2012

  28. NHANES CNCfHS (2012, Jan) NHANES 2001–2002: urinary phthalates, phytoestrogens and PAHs data documentation, codebook, and frequencies. http://www.cdc.gov/nchs/nhanes/nhanes2001-2002/PHPYPA_B.htm. Accessed 01 Oct 2012

  29. NHANES CNCfHS (2009, Aug) NHANES 2003–2004: urinary phytoestrogens data documentation, codebook, and frequencies. http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/L06PHY_C.htm. Accessed 01 Oct 2012

  30. NHANES CNCfHS (2010, May 14) NHANES—NHANES 1999–2000—lab methods. http://www.cdc.gov/nchs/nhanes/nhanes1999-2000/lab_methods_99_00.htm. Accessed 01 Oct 2012

  31. Barnes S, Coward L, Kirk M et al (1998) HPLC-mass spectrometry analysis of isoflavones. Proc Soc Exp Biol Med 217(3):254–262

    Article  CAS  Google Scholar 

  32. NHANES CNCfHS (2010, May 14) NHANES—NHANES 2003–2004—lab methods. http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/lab_methods_03_04.htm. Accessed 01 Oct 2012

  33. Westgard JO (2003) Internal quality control: planning and implementation strategies. Ann Clin Biochem 40(6):593–611. doi:10.1258/000456303770367199

    Article  Google Scholar 

  34. NHANES CNCfHS (2008, May) NHANES 2003–2004 triglycerides and LDL-cholesterol. http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/L13AM_C.htm

  35. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502

    Google Scholar 

  36. Grundy SM (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112(17):2735–2752. doi:10.1161/CIRCULATIONAHA.105.169404

    Article  Google Scholar 

  37. de Kleijn MJJ, van der Schouw YT, Wilson PWF et al (2002) Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S. women: the Framingham study. J Nutr 132(2):276–282

    Google Scholar 

  38. Cornish SM, Chilibeck PD, Paus-Jennsen L et al (2009) A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults. Appl Physiol Nutr Metab 34(2):89–98. doi:10.1139/H08-142

    Article  CAS  Google Scholar 

  39. Yang G, Shu XO, Jin F et al (2004) Soyfood consumption and risk of glycosuria: a cross-sectional study within the Shanghai Women’s Health Study. Eur J Clin Nutr 58(4):615–620. doi:10.1038/sj.ejcn.1601855

    Article  CAS  Google Scholar 

  40. Goodman-Gruen D, Kritz-Silverstein D (2001) Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 131(4):1202–1206

    CAS  Google Scholar 

  41. Kuijsten A, Arts ICW, Vree TB et al (2005) Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside. J Nutr 135(4):795–801

    CAS  Google Scholar 

  42. Setchell KDR, Faughnan MS, Avades T et al (2003) Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am J Clin Nutr 77(2):411–419

    CAS  Google Scholar 

  43. Bloedon LT, Jeffcoat AR, Lopaczynski W et al (2002) Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. Am J Clin Nutr 76(5):1126–1137

    CAS  Google Scholar 

  44. Nielsen ILF, Williamson G (2007) Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr Cancer 57(1):1–10. doi:10.1080/01635580701267677

    Article  CAS  Google Scholar 

  45. Valentín-Blasini L, Blount BC, Caudill SP et al (2003) Urinary and serum concentrations of seven phytoestrogens in a human reference population subset. J Expo Anal Environ Epidemiol 13(4):276–282. doi:10.1038/sj.jea.7500278

    Article  Google Scholar 

  46. Dixon RA (2004) Phytoestrogens. Annu Rev Plant Biol 55(1):225–261. doi:10.1146/annurev.arplant.55.031903.141729

    Article  CAS  Google Scholar 

  47. Merritt JC (2004) Metabolic syndrome: soybean foods and serum lipids. J Natl Med Assoc 96(8):1032–1041

    Google Scholar 

  48. Pan A, Yu D, Demark-Wahnefried W et al (2009) Meta-analysis of the effects of flaxseed interventions on blood lipids. Am J Clin Nutr 90(2):288–297. doi:10.3945/ajcn.2009.27469

    Article  CAS  Google Scholar 

  49. Drewnowski A (2012) The economics of food choice behavior: why poverty and obesity are linked. Nestle Nutr Inst Workshop Ser 73:95–112. doi:10.1159/000341303

    Article  Google Scholar 

  50. Heo M, Kim RS, Wylie-Rosett J et al (2011) Inverse association between fruit and vegetable intake and BMI even after controlling for demographic, socioeconomic and lifestyle factors. Obes Facts 4(6):449–455. doi:10.1159/000335279

    Article  Google Scholar 

  51. Lutfiyya MN, Chang LF, Lipsky MS (2012) A cross-sectional study of US rural adults’ consumption of fruits and vegetables: do they consume at least five servings daily? BMC Public Health 12:280. doi:10.1186/1471-2458-12-280

    Article  Google Scholar 

  52. NHANES CNCfHS (2011–2014) NHANES 2011–2012. Asian oversampling. http://www.cdc.gov/nchs/nhanes/nhanes2011-2012/nhanes11_12.htm. Accessed 26 Nov 2012

  53. Vergne S, Sauvant P, Lamothe V et al (2009) Influence of ethnic origin (Asian v. Caucasian) and background diet on the bioavailability of dietary isoflavones. Br J Nutr 102(11):1642. doi:10.1017/S0007114509990833

    Article  CAS  Google Scholar 

  54. Kunisue T, Tanabe S, Isobe T et al (2010) Profiles of phytoestrogens in human urine from several Asian countries. J Agric Food Chem 58(17):9838–9846. doi:10.1021/jf102253j

    Article  CAS  Google Scholar 

  55. Meeuwisse-Pasterkamp SH, van der Klauw MM, Wolffenbuttel BHR (2008) Type 2 diabetes mellitus: prevention of macrovascular complications. Expert Rev Cardiovasc Ther 6(3):323–341. doi:10.1586/14779072.6.3.323

    Article  CAS  Google Scholar 

  56. Grundy SM (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109(3):433–438. doi:10.1161/01.CIR.0000111245.75752.C6

    Article  Google Scholar 

  57. Cederroth CR, Vinciguerra M, Gjinovci A et al (2008) Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism. Diabetes 57(5):1176–1185. doi:10.2337/db07-0630

    Article  CAS  Google Scholar 

  58. Aoyama T, Fukui K, Nakamori T et al (2000) Effect of soy and milk whey protein isolates and their hydrolysates on weight reduction in genetically obese mice. Biosci Biotechnol Biochem 64(12):2594–2600

    Article  CAS  Google Scholar 

  59. Choi MS, Jung UJ, Yeo J et al (2008) Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab Res Rev 24(1):74–81. doi:10.1002/dmrr.780

    Article  CAS  Google Scholar 

  60. Lee CC, Bloem CJ, Kasa-Vubu JZ et al (2012) Effect of oral phytoestrogen on androgenicity and insulin sensitivity in postmenopausal women. Diabetes Obes Metab 14(4):315–319. doi:10.1111/j.1463-1326.2011.01532.x

    Article  CAS  Google Scholar 

  61. Marinangeli CPF, Jones PJH (2011) Whole and fractionated yellow pea flours reduce fasting insulin and insulin resistance in hypercholesterolaemic and overweight human subjects. Br J Nutr 105(1):110–117. doi:10.1017/S0007114510003156

    Article  CAS  Google Scholar 

  62. Hall WL, Vafeiadou K, Hallund J et al (2006) Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 83(3):592–600

    CAS  Google Scholar 

  63. Morisset A, Lemieux S, Veilleux A et al (2009) Impact of a lignan-rich diet on adiposity and insulin sensitivity in post-menopausal women. Br J Nutr 102(2):195–200. doi:10.1017/S0007114508162092

    Article  CAS  Google Scholar 

  64. Rosero Arenas MA, Rosero Arenas E, Portaceli Armiñana MA et al (2008) Utilidad de los fitoestrógenos en la reducción de la presión arterial. Revisión sistemática y metaanálisis (Usefulness of phyto-oestrogens in reduction of blood pressure. Systematic review and meta-analysis). Aten Primaria 40(4):177–186

    Article  Google Scholar 

  65. Taddei S (2009) Blood pressure through aging and menopause. Climacteric 12(Suppl 1):36–40

    Article  Google Scholar 

  66. Weggemans RM, Trautwein EA (2003) Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur J Clin Nutr 57(8):940–946. doi:10.1038/sj.ejcn.1601628

    Article  CAS  Google Scholar 

  67. McPherson R, Frohlich J, Fodor G et al (2006) Canadian Cardiovascular Society position statement–recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 22(11):913–927

    Article  Google Scholar 

  68. Erberich LCN, Alcantara VM, Picheth G et al (2002) Hormone replacement therapy in postmenopausal women and its effects on plasma lipid levels. Clin Chem Lab Med 40(5):446–451. doi:10.1515/CCLM.2002.076

    CAS  Google Scholar 

  69. Eisenberg DM, Kessler RC, Foster C et al (1993) Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328(4):246–252. doi:10.1056/NEJM199301283280406

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This project has been funded by Swiss Foundation for Nutrition Research (SFEFS; Zürich, Switzerland).

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Division of Cancer Epidemiology and Prevention, Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland

    Tristan Struja, Aline Richard, Monika Eichholzer & Sabine Rohrmann

  2. Helmholtz Center Munich, German Research Center for Environmental Health, Institute of Epidemiology I, Neuherberg, Germany

    Jakob Linseisen

Authors
  1. Tristan Struja
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aline Richard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jakob Linseisen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Monika Eichholzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sabine Rohrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sabine Rohrmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Struja, T., Richard, A., Linseisen, J. et al. The association between urinary phytoestrogen excretion and components of the metabolic syndrome in NHANES. Eur J Nutr 53, 1371–1381 (2014). https://doi.org/10.1007/s00394-013-0639-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-013-0639-y

Keywords

Search

Navigation